CHMP5 and infection: These variants pose the highest resistance to previously raised (whether by vaccination or prior infection) antibodies yet due to its mutations in the spike protein and RBD, and are likely to reduce the efficacy of EpF(ab’)2 which were raised against RBD of the SARS-CoV-2 ancestral strain.